GUADALAJARA, Mexico, April 04, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger ...

Horizon's main protagonist Aloy, has a unique, complicated post-apocalyptic history and massive potential beyond the mainline ...

ISLAMABAD: While withholding an amount of Rs 2 billion of K-Electric, National Electric Power Regulatory Authority (Nepra) has allowed negative adjustment of Rs 3.021 per unit for KE’s consumers for ...

NEW YORK (AP) — Rihanna is accustomed to defying convention.

Q4-2024 and Annual Summary: Q4-2024 funded volumes of $19.6 billion and annual funded volume of $67.4, representing a 38% and 19% increase as compared to 2023, respectively; Q4-2024 revenue of $22.3 ...

Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announced today the release of financial and operating results for the fourth quarter ...

Piper Sandler downgraded Elevation to “Neutral” from “Overweight” and slashed its price target to $0.70 from prior levels, ...

Wedbush downgraded Elevation Oncology (ELEV) to Neutral from Outperform with a price target of $1.60, down from $5, after the company announced ...

31 to Rs. 3,524 whereas that to ten gram silver went down by Rs. 26 to Rs. 3,021. The price of gold in the international market increased by $12 to $3,050 from $3,038 whereas price of silver went ...

In the safety analysis of all enrolled patients (n=85), treatment with EO-3021 was observed to be generally well-tolerated, with an adverse event profile consistent with previously reported data ...

EO-3021 is a Claudin 18.2 antibody-drug conjugate (ADC), which Elevation Oncology was developing for the treatment of advanced, unresectable or metastatic gastric and gastroesophageal junction ...